IND Swift Limited
Indian Pharmaceutical Exporter · Antihistamines & Allergy Specialist · $36.7M Total Trade · DGFT Verified
IND Swift Limited is an Indian pharmaceutical exporter with a total trade value of $36.7M across 13 products in 9 therapeutic categories. Based on 1,476 verified export shipments from Indian Customs (DGFT) records, IND Swift Limited is the #1 Indian exporter in 1 product including Sulfasalazine. Top exports include Fexofenadine ($16.9M), Ramipril ($7.6M), Clarithromycin ($2.9M).
IND Swift Limited — Export Portfolio & Destination Treemap

Who is IND Swift Limited? — Company Overview & Market Position
Ind-Swift Limited, established in 1986, is a Chandigarh-based pharmaceutical company specializing in the development and export of finished pharmaceutical formulations. The company was founded by three visionaries: the Mehtas, the Munjals, and the Jains, who aimed to create a global enterprise rooted in ethical practices. Ind-Swift Limited is a privately held entity, with a promoter holding of 55.58% and public holding of 44.42% as of 2024. The company is listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) under the ticker symbols BSE:524652 and NSE:INDSWFTLTD, respectively. As of August 13, 2025, the company's stock price was ₹15.76. Ind-Swift Limited employs approximately 1,054 individuals. The company's official website is www.indswiftltd.com.